Acquisition of Endospan (Tables)

9 Months Ended

Sep. 30, 2026

The preliminary purchase consideration allocated as of the Acquisition Date consisted of the following (in thousands):


Consideration
Cash consideration	$	107,042
Debt obligations settled in cash by Artivion	14,206
Noncash settlement of preexisting relationships and Endospan Option (1)	31,000
Contingent consideration	21,782
Fair value of total consideration transferred	$	174,030

Purchase Price Allocation
Cash and cash equivalents	$	4,363
Intangible assets, net	72,400
Net other assets/liabilities acquired	2,601
Goodwill	94,666
Net assets acquired	$	174,030

(1) Represents amounts included in consideration transferred in connection with the settlement or exercise of preexisting contractual relationships between Artivion and Endospan, consisting of the acquisition-date fair value of the effective settlement of the Endospan Loans ($24.9 million) and the Buyer Deposits ($3.0 million), and the carrying amount of the Endospan Option ($3.1 million) upon exercise. See “Settlement of Preexisting Relationships and Endospan Option” below.

Schedule of Intangible Asset Acquired

The following table presents details of the identifiable intangible assets recognized in connection with the Endospan Acquisition (in thousands, except estimated useful life):


Identifiable Intangible Assets	Fair Value		Estimated Useful Life (Years)
Developed technology	$	31,800	10.0
Trade name	1,700		15.0
In-process research and development (“IPR&D”)	38,900		Indefinite
Total identifiable intangible assets	$	72,400